Log In
Log In
Client Account Access
Equity Research Access
Financial Strategies Client Portal
Macro Research Access
Merchant Banking Investor Access
Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy & Power
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
Insights
News
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Read more
about DayOneBio-2023-06-06
$172.5 Million
Image
Day One Biopharmaceuticals, Inc.
Confidentally Marketed Follow-On Offering
Active Bookrunner
Read more
about Corebridge-2023-06-08
$1.2 Billion
Image
Corebridge Financial, Inc
Follow-On Offering
Active Bookrunner
Read more
about Enfusion-2023-10-01
$318.8 Million
Image
Enfusion
Initial Public Offering
Active Bookrunner
Read more
about Corebridge-22-09-01
$1.7 Billion
Image
Image
Corebridge
Initial Public Offering
Active Bookrunner
Read more
about TELA-2023-04-18
$49.6 Million
Image
TELA Bio, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about ReneoPharmaceuticals-2023-05-03
$68.3 Million
Image
Reneo Pharmaceuticals
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Acelyrin-2023-05-04
$621.0 Million
Image
Acelyrin, Inc.
Initial Public Offering
Active Bookrunner
Read more
about Protagonist-2023-04-04
$100.0 Million
Image
Protagonist Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about AspenAerogels-2022-12-01
Image
Aspen Aerogels, Inc.
At The Market Offering
Active Bookrunner
Read more
about Redwood-2023-01-10
$65.0 Million
Image
Redwood Trust
Preferred Stock
Active Bookrunner
Pagination
Previous page
‹‹
Page 5
Next page
››
Subscribe to Active Bookrunner
